This is consistent with the aforementioned phenomenon that BRCA1-associated human breast tumors have significantly increased chance of carrying TP53 mutations, compared to BRCA1-unrelated breast tumors [7,64]. The gene discussed is BRCA1; the disease is breast neoplasm.